İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2022 · article

Novel biochemical prognostic indicators in COVID-19: Can CRP/albumin, urea/albumin, and LDH/albumin ratios be used to predict mortality and length of hospitalization?

Dergi Medical Science and Discovery
ISSN2148-6832
YÖKSİS OpenAlex Açık erişim · diamond
Yıl2022
Atıf6OpenAlex
Yüzdelik%65,0
FWCI0,591,00 = dünya ortalaması

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıMedical Science and Discovery
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

Objective: As the coronavirus disease 2019 (COVID-19) pandemic continues, clinical and laboratory predictors of progression to serious and lethal types of the illness are urgently needed. We aimed to investigate how well hematologic, biochemical, and immunologic biomarkers could distinguish between patients with and without severe or fatal COVID-19. Material and Methods: This retrospective study was performed in the internal medicine departments of two institutions. Data were collected from the hospital database, and the medical files of 280 adult COVID-19 were reviewed. The relationship between hematologic and biochemical parameters which include C-reactive protein (CRP)/albumin, urea/albumin, and lactate dehydrogenase (LDH)/albumin ratios and length of hospitalization, disease severity, and survival were investigated. Results: Our series consisted of 280 adult COVID-19 patients (147 women, 133 men) with an average age of 58.34 ± 18.64 (range: 19 to 93). Most patients (n=171, 61.1%) had mild-moderate disease, while severe disease was diagnosed in 109 cases (38.9%). A total of 36 patients died due to COVID-19 yielding a mortality rate of 12.9%. The average length of hospitalization was 8.98 ± 5.80 days (range: 1-55 days). We noted that (CRP)/albumin, urea/albumin, and lactate dehydrogenase (LDH)/albumin ratios were significantly associated with severity of disease, mortality, and length of hospitalization. Conclusion: Several biomarkers have been established that could help with risk stratification models for predicting serious and fatal results of COVID-19 infection. We suggest that clinicians closely track CRP/albumin, urea/albumin, and LDH/albumin ratios in hospitalized patients with respiratory distress as indicators for possible critical illness progression.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

6atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 2 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2023 Significance of laboratory biomarkers in monitoring patients with COVID-19 pneumoniaAtıf 2 · OpenAlex
  2. 2023 Significance of laboratory biomarkers in monitoring patients with COVID-19 pneumoniaAtıf 2 · OpenAlex

Yazarlar

9
  1. ZEYNEP ERGENÇ YALOVA ÜNİVERSİTESİ 1
  2. HASAN ERGENÇ 2
  3. SONGÜL DOĞAN ARAÇ 3
  4. MUSTAFA USANMAZ 4
  5. ERSİN ALKILINÇ 5
  6. Gülsüm Kaya 6
  7. CENGİZ KARACAER 7
  8. AHMET NALBANT 8
  9. TEZCAN KAYA 9